Hormonal Effects of Apomorphine and Cholecystokinin in Pigs: Modification of the Response to Cholecystokinin by a Dopamine Antagonist (Metoclopramide) and a Kappa Opioid Agonist (PD117302)

European Journal of Endocrinology - United Kingdom
doi 10.1530/acta.0.1250420
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Heteromerization of Μ-Opioid Receptor and Cholecystokinin B Receptor Through the Third Transmembrane Domain of the Μ-Opioid Receptor Contributes to the Anti-Opioid Effects of Cholecystokinin Octapeptide

Experimental and Molecular Medicine
BiochemistryMedicineClinical BiochemistryMolecular BiologyMolecular Medicine
2018English

Study of a Structurally Similar Kappa Opioid Receptor Agonist and Antagonist Pair by Molecular Dynamics Simulations

Journal of Molecular Modeling
Organic ChemistryTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsMathematicsComputational TheoryCatalysisPhysical
2010English

Effects of a Cholecystokinin Receptor Antagonist on Intestinal Phase of Pancreatic and Biliary Responses in Man.

Journal of Clinical Investigation
Medicine
1990English

Effects of Spiradoline Mesylate, a Selective .KAPPA.-Opioid-Receptor Agonist, on the Central Dopamine System With Relation to Mouse Locomotor Activity and Analgesia.

The Japanese Journal of Pharmacology
1993English

Physiological Role of Cholecystokinin on Postprandial Insulin Secretion and Gastric Meal Emptying in Man. Studies With the Cholecystokinin Receptor Antagonist Loxiglumide

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1991English

Synthesis of Constrained Analogues of Cholecystokinin/Opioid Chimeric Peptides

Tetrahedron Letters
Organic ChemistryBiochemistryDrug Discovery
2006English

Cholecystokinin Potentiates Dopamine-Mediated Behaviors: Evidence for Modulation Specific to a Site of Coexistence

Journal of Neuroscience
Neuroscience
1985English

Elimination of a Cholecystokinin Receptor Agonist ‘Trigger’ in an Effort to Develop Positive Allosteric Modulators Without Intrinsic Agonist Activity

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2015English

Cholecystokinin Receptor-1 Mediates the Inhibitory Effects of Exogenous Cholecystokinin Octapeptide on Cellular Morphine Dependence

BMC Neuroscience
NeuroscienceCellularMolecular Neuroscience
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy